Decreasing Emergence Agitation With Personalized Music
Launched by STANFORD UNIVERSITY · Sep 9, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether playing personalized music can help reduce a condition called emergence agitation (EA) in children recovering from certain surgeries. Emergence agitation can cause confusion and restlessness as kids wake up from anesthesia. The researchers believe that listening to music that is meaningful to the child may help ease their anxiety and discomfort, making their recovery smoother. The goal is to see if this approach can improve overall care, minimize the need for extra medications or nursing help, and make parents and caregivers happier with the recovery process.
Children aged 3 to 9 who are having specific surgeries, like tonsil removal or ear procedures, may be eligible to participate. In this study, participants will be randomly assigned to either listen to their personalized music along with standard care or to receive standard care alone. Those in the music group will enjoy the music both before and after their surgery. This trial is currently recruiting participants, and it's important to note that children with certain medical issues or those who do not enjoy music may not qualify.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • patient ages 3-9 (chosen due to high incidence of emergence delirium and presence of musical memory seen in this age group)
- • unilateral or bilateral myringotomy procedure, laser treatment for skin lesions, adenoidectomy without tonsillectomy
- • tonsillectomy with or without adenoidectomy
- • Exclusion Criteria
- • Chronic intake of any sedative or analgesic medication
- • Combined surgical procedure not otherwise listed in inclusion criteria
- • Surgical or anesthetic complications (including use of invasive airway device for myringotomy)
- • History of significant hearing loss impeding the ability to hear music
- • Lack of interest in music reported by parents or inability to identify personally meaningful music
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Saint Louis, Missouri, United States
Burlington, Vermont, United States
Saint Louis, Missouri, United States
Patients applied
Trial Officials
R J Ramamurthi, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials